It has been found that EPB41L1 and SH3PXD2A have no statistically significant prognostic values in determining the disease-specific survival, overall survival, and progression-free survival of GBM patients (Fig. 3E). The gene discussed is SH3PXD2A; the disease is glioblastoma.